Roger R. Reddel

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts

  Clinical Cancer Research · 2026-04-09

• Correction: Targeted Therapy of <i>TERT</i> -Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

  Clinical Cancer Research · 2026-03-16

• Large-scale drug sensitivity, gene dependency, and proteogenomic analyses of telomere maintenance mechanisms in cancer cells

  Nature Communications · 2025-12-23 · 3 citations

• Predictive Biomarkers of Antibody–Drug Conjugate Efficacy for Solid Tumors: Current Challenges and the Potential Role of Quantitative Proteomics

  Clinical Cancer Research · 2025-12-22 · 3 citations

• Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients

  Universität Zürich, ZORA · 2025-12-01

• Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients

  Life Science Alliance · 2025-11-19

• Machine Learning-Driven Discovery of Synergistic Protein Interactions Identifies ATL3 as a Putative Biomarker for Cancer Drug ResponsePreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-11-07

• A proteomic signature derived by ensemble machine learning for predicting relapse in pediatric B cell acute lymphoblastic leukemia

  Blood · 2025-11-03

• Mechanosensitive Stanniocalcin-1 Attenuates Pulmonary Arterial Hypertension by Suppressing Smooth Muscle Cell ProliferationPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-10-15

• Table S4 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Supplementary Figure 9 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Table S1 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Supplementary Figure 5 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Supplementary Figure 7 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Supplementary Figure 3 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Table S2 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Supplementary Figure 13 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Supplementary Figure 8 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Data from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04

• Supplementary Figure 11 from Federated Deep Learning Enables Cancer Subtyping by ProteomicsPreprint

  2025-09-04